Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical businesses, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably protected for use - and failure to do so might be grounds for compensation. Our lawyers are functioning challenging to get those hurt by the drug the compensation they may be entitled to.Although bleeding is really a frequent complication related with anticoagulants, it has been alleged that Xarelto is more unsafe than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This means that, in the event of an emergency, patients could be at threat for irreversible bleeding problems, like life-threatening internal and gastrointestinal hemorrhaging.
In the event you or possibly a loved a single suffered a serious bleeding event right after taking Xarelto, you might have legal recourse. For far more data, make contact with us today to possess your case reviewed, cost-free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future health-related bills, lost wages, discomfort and suffering and, in situations of death, funeral costs. Moreover, they are searching for punitive damages, which are typically awarded to punish the defendant and deter other firms from xareltonews.netlify.com acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.
Visit this page for much more information on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.